BackChina Botanic Pharmaceutical Overview

China Botanic Pharmaceutical Receivables

Track China Botanic Pharmaceutical's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

China Botanic Pharmaceutical Receivables History

Loading

China Botanic Pharmaceutical vs. peers: Receivables Comparison

Loading

China Botanic Pharmaceutical Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

China Botanic Pharmaceutical (CBPI) FAQ

The latest receivables for CBPI is $0 as of July 2025. In the prior-year period, the figure was $0. Investors often review this figure alongside China Botanic Pharmaceutical's historical trend and sector peers before judging valuation or financial health.

Over the past year, CBPI's receivables moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in China Botanic Pharmaceutical's operating scale or balance-sheet position.

A receivables figure of $0 for CBPI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CBPI's receivables ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.